High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype

Nutrition and Cancer

Volumn 65, Issue 3, 2013, Pages 398-409

  Lowcock, Elizabeth C ^a   Cotterchio, Michelle ^a,b   Anderson, Laura N ^a,b   Boucher, Beatrice A ^a,b,c   El Sohemy, Ahmed ^b  

^a CANCER CARE ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2; ESTROGEN RECEPTOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANADA; CANCER REGISTRY; CANCER RISK; COFFEE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MODIFICATION; ETHNICITY; FEMALE; FIRST DEGREE RELATIVE; FLUID INTAKE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; SMOKING;

ADULT; AGED; BREAST NEOPLASMS; CAFFEINE; CASE-CONTROL STUDIES; COFFEE; CYTOCHROME P-450 CYP1A2; DIET; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; ONTARIO; POSTMENOPAUSE; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 84876120250     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.768348     Document Type: Article

References (64)

1. Snowdon, D A, and, Phillips, R L. 1984. Coffee consumption and risk of fatal cancers. Am J Public Health, 74: 820-823.
2. Lubin, F, Ron, E, Wax, Y, and, Modan, B. 1985. Coffee and methylxanthines and breast cancer: a case-control study. J Natl Cancer Inst, 74: 569-573.
3. Yu, X, Bao, Z, Zou, J, and, Dong, J. 2011. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer, 11. E96
4. Tang, N, Zhou, B, Wang, B, and, Yu, R. 2009. Coffee consumption and risk of breast cancer: a metaanalysis. Am J Obstet Gynecol, 200: E290
5. Gierach, G L, Freedman, N D, Andaya, A, Hollenbeck, A R, Park, Y. 2012. Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. Int J Cancer, 131: 452-460.
6. Fagherazzi, G, Touillaud, M S, Boutron-Ruault, M C, Clavel-Chapelon, F, and, Romieu, I. 2011. No association between coffee, tea or caffeine consumption and breast cancer risk in a prospective cohort study. Public Health Nutr, 14: 1315-1320.
7. Boggs, D A, Palmer, J R, Stampfer, M J, Spiegelman, D, Adams-Campbell, L L. 2010. Tea and coffee intake in relation to risk of breast cancer in the Black Women's Health Study. Cancer Causes Control, 21: 1941-1948.
8. Nilsson, L M, Johansson, I, Lenner, P, Lindahl, B, and, Van Guelpen, B. 2010. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control, 21: 1533-1544.
9. Li, J, Seibold, P, Chang-Claude, J, Flesch-Janys, D, Liu, J. 2011. Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Res, 13. E49
10. Kotsopoulos, J, Eliassen, A H, Missmer, S A, Hankinson, S E, and, Tworoger, S S. 2009. Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer, 115: 2765-2774.
11. Goto, A, Song, Y, Chen, B H, Manson, J E, Buring, J E. 2011. Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women. Diabetes, 60: 269-275.
12. Jernström, H, Klug, T L, Sepkovic, D W, Bradlow, H L, and, Narod, S A. 2003. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Carcinogenesis, 24: 991-1005.
13. Woolcott, C G, Shvetsov, Y B, Stanczyk, F Z, Wilkens, L R, White, K K. 2010. Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer, 17: 125-134.
14. Kaaks, R, Rinaldi, S, Key, T J, Berrino, F, Peeters, P H. 2005. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer, 12: 1071-1082.
15. Zeleniuch-Jacquotte, A, Shore, R E, Koenig, K L, Akhmedkhanov, A, Afanasyeva, Y. 2004. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer, 90: 153-159.
16. Walker, K, Bratton, D J, and, Frost, C. 2011. Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis. Br J Cancer, 105: 1451-1457.
17. Obi, N, Vrieling, A, Heinz, J, and, Chang-Claude, J. 2011. Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?. Int J Womens Health, 3: 37-51.
18. Larsson, S C, Bergkvist, L, and, Wolk, A. 2009. Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Causes Control, 20: 2039-2044.
19. Michels, K B, Holmberg, L, Bergkvist, L, and, Wolk, A. 2002. Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. Ann Epidemiol, 12: 21-26.
20. Smith, S J, Deacon, J M, and, Chilvers, C E. 1994. Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group. Br J Cancer, 70: 112-119.
21. Folsom, A R, McKenzie, D R, Bisgard, K M, Kushi, L H, and, Sellers, T A. 1993. No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women's Health Study. Am J Epidemiol, 138: 380-383.
22. Rohan, T E, and, McMichael, A J. 1988. Methylxanthines and breast cancer. Int J Cancer, 41: 390-393.
23. Ishitani, K, Lin, J, Manson, J E, Buring, J E, and, Zhang, S M. 2008. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med, 168: 2022-2031.
24. Ganmaa, D, Willett, W C, Li, T Y, Feskanich, D, van Dam, R M. 2008. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer, 122: 2071-2076.
25. Zhou, S F, Yang, L P, Zhou, Z W, Liu, Y H, and, Chan, E. 2009. Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2. AAPS J, 11: 481-494.
26. Amin, N, Byrne, E, Johnson, J, Chenevix-Trench, G, Walter, S. Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry,. [published online ahead of print August 30, 2011]
27. Cornelis, M C, Monda, K L, Yu, K, Paynter, N, Azzato, E M. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet, 7 2033. E100, 2011
28. Sulem, P, Gudbjartsson, D F, Geller, F, Prokopenko, I, Feenstra, B. 2011. Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet, 20: 2071-2077.
29. Djordjevic, N, Ghotbi, R, Jankovic, S, and, Aklillu, E. 2010. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism. Eur J Clin Pharmacol, 66: 697-703.
30. Ghotbi, R, Christensen, M, Roh, H K, Ingelman-Sundberg, M, Aklillu, E. 2007. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans. Eur J Clin Pharmacol, 63: 537-546.
31. Sachse, C, Brockmoller, J, Bauer, S, and, Roots, I. 1999. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol, 47: 445-449.
32. Palatini, P, Ceolotto, G, Ragazzo, F, Dorigatti, F, Saladini, F. 2009. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens, 27: 1594-1601.
33. Cornelis, M C, El-Sohemy, A, Kabagambe, E K, and, Campos, H. 2006. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA, 295: 1135-1141.
34. Goodman, M T, Tung, K H, McDuffie, K, Wilkens, L R, and, Donlon, T A. 2003. Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer, 46: 23-29.
35. Kotsopoulos, J, Ghadirian, P, El-Sohemy, A, Lynch, H T, Snyder, C. 2007. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev, 16: 912-916.
36. Bhoo Pathy, N, Peeters, P, van Gils, C, Beulens, J W, van der Graaf, Y. 2010. Coffee and tea intake and risk of breast cancer. Breast Cancer Res Treat, 121: 461-467.
37. Brown, J, Kreiger, N, Darlington, G A, and, Sloan, M. 2001. Misclassification of exposure: coffee as a surrogate for caffeine intake. Am J Epidemiol, 153: 815-820.
38. Cotterchio, M, Boucher, B A, Kreiger, N, Mills, C A, and, Thompson, L U. 2008. Dietary phytoestrogen intake-lignans and isoflavones-and breast cancer risk (Canada). Cancer Causes Control, 19: 259-272.
39. Anderson, L N, Cotterchio, M, Cole, D E, and, Knight, J A. 2011. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev, 20: 1708-1717.
40. Boucher, B, Cotterchio, M, Kreiger, N, Nadalin, V, Block, T. 2006. Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr, 9: 84-93.
41. Willett, W C, Stampfer, M J, Manson, J E, Colditz, G A, Rosner, B A. 1996. Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA, 275: 458-462.
42. Health Canada. Caffeine in Food, Ottawa, Canada: Government of Canada. Retrieved from http://www.hc-sc.gc.ca/fn-an/securit/addit/caf/food-caf-aliments- eng.php
43. Maldonado, G, and, Greenland, S. 1993. Simulation study of confounder selection strategies. Am J Epidemiol, 138: 923-936.
44. Djordjevic, N, Ghotbi, R, Bertilsson, L, Jankovic, S, and, Aklillu, E. 2008. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. Eur J Clin Pharmacol, 64: 381-385.
45. Karp, S E, Tonin, P N, Bégin, L R, Martinez, J J, Zhang, J C. 1997. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer, 80: 435-441.
46. Lakhani, S R, Van De Vijver, M J, Jacquemier, J, Anderson, T J, Osin, P P. 2002. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol, 20: 2310-2318.
47. Honrado, E, Benítez, J, and, Palacios, J. 2006. Histopathology of BRCA1- and BRCA2-associated breast cancer. Crit Rev Oncol Hematol, 59: 27-39.
48. Halvorsen, B L, Carlsen, M H, Phillips, K M, Bøhn, S K, Holte, K. 2006. Content of redox-active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr, 84: 95-135.
49. Wang, Y, and, Ho, C T. 2009. Polyphenolic chemistry of tea and coffee: a century of progress. J Agric Food Chem, 57: 8109-8114.
50. Clifford, M N. 1999. Chlorogenic acids and other cinnamates: nature, occurrence and dietary burden. J Agric Food Chem, 79: 362-372.
51. Daglia, M, Racchi, M, Papetti, A, Lanni, C, Govoni, S. 2004. In vitro and ex vivo antihydroxyl radical activity of green and roasted coffee. J Agric Food Chem, 52: 1700-1704.
52. Key, T J. 2011. Fruit and vegetables and cancer risk. Br J Cancer, 104: 6-11.
53. Michels, K B, Mohllajee, A P, Roset-Bahmanyar, E, Beehler, G P, and, Moysich, K B. 2007. Diet and breast cancer: a review of the prospective observational studies. Cancer, 109: 2712-2749.
54. Thompson, L U, Boucher, B A, Liu, Z, Cotterchio, M, and, Kreiger, N. 2006. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer, 54: 184-201.
55. Buck, K, Zaineddin, A K, Vrieling, A, Linseisen, J, and, Chang-Claude, J. 2010. Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr, 92: 141-153.
56. McCann, S E, Hootman, K C, Weaver, A M, Thompson, L U, Morrison, C. 2012. Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. J Nutr, 142: 91-98.
57. McCann, S E, Kulkarni, S, Trevisan, M, Vito, D, Nie, J. 2006. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat, 99: 309-311.
58. Alves, R C, Costa, A S, Jerez, M, Casal, S, Sineiro, J. 2010. Antiradical activity, phenolics profile, and hydroxymethylfurfural in espresso coffee: influence of technological factors. J Agric Food Chem, 58: 12221-12229.
59. Farah, A, de Paulis, T, Moreira, D P, Trugo, L C, and, Martin, P R. 2006. Chlorogenic acids and lactones in regular and water-decaffeinated Arabica coffees. J Agric Food Chem, 54: 374-381.
60. Health Canada. Canadian Nutrient File, Ottawa, Canada: Government of Canada. Retrieved from http://webprod3.hc-sc.gc.ca/cnf-fce/index-eng.jsp
61. Bell, L N, Wetzel, C R, and, Grand, A N. 1996. Caffeine content in coffee as influenced by grinding and brewing techniques. Food Res Int, 29: 785-789.
62. Andrews, K W, Schweitzer, A, Zhao, C, Holden, J M, Roseland, J M. 2007. The caffeine contents of dietary supplements commonly purchased in the US: analysis of 53 products with caffeine-containing ingredients. Anal Bioanal Chem, 389: 231-239.
63. Higgins, J P, Tuttle, T D, and, Higgins, C L. 2010. Energy beverages: content and safety. Mayo Clin Proc, 85: 1033-1041.
64. Ferlay, J, Shin, H R, Bray, F, Forman, D, and, Mathers, C. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10, Lyon, France: International Agency for Research on Cancer. Retrieved from http://globocan.iarc.fr